Clinical care guidelines for cystic fibrosis-related diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

Diabetes Care

Volumn 33, Issue 12, 2010, Pages 2697-2708

  Moran, Antoinette ^a   Brunzell, Carol ^a   Cohen, Richard C ^b,n   Katz, Marcia ^c,n   Marshall, Bruce C ^d   Onady, Gary ^e,n   Robinson, Karen A ^f   Sabadosa, Kathryn A ^g   Stecenko, Arlene ^h,n   Slovis, Bonnie ^i,u   Alexander, Paula ^j   Beall, Robert J ^d   Becker, Dorothy ^k,l   Campbell III, Preston W ^d   Casella, Samuel J ^m   Chin, Melissa ^d   Brooks, Joan Finnegan ^o   George, Cynthia ^d   Gottlieb, Peter A ^p   Hazle, Leslie ^d   Kirkman, M Sue ^q   McKeon, Catherine ^r   Rodgers, Theresa ^s   Schindler, Terri ^t   Wood, Mary E ^v   Young, David ^w   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b KAISER PERMANENTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CYSTIC FIBROSIS FOUNDATION   (United States)

^e WRIGHT STATE UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j East Tennessee Children's Hospital   (United States)

^k CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^l UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^m CHILDREN S HOSPITAL AT DARTMOUTH   (United States)

ⁿ Screening Subcommittee ^*  (United States)

^o Patient Focused Market Research   (United States)

^p UNIVERSITY OF COLORADO DENVER   (United States)

^q ADA   (United States)

^r NATIONAL INSTITUTES OF HEALTH   (United States)

^s UNIVERSITY OF ALABAMA   (United States)

^t CASE WESTERN RESERVE UNIVERSITY   (United States)

^u VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^v DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^w Intermountain Cystic Fibrosis Adult Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALCOHOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; CARBOHYDRATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAT; GLIBENCLAMIDE; GLUCAGON; GLUCOCORTICOID; GLUCOSE; INSULIN; MEGLITINIDE; METFORMIN; MINERAL; ORAL ANTIDIABETIC AGENT; PROTEIN; REPAGLINIDE; SODIUM; VITAMIN;

ACUTE DISEASE; AEROBIC EXERCISE; AGE; ANTIBIOTIC THERAPY; BLOOD GLUCOSE MONITORING; CALORIE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; COUGHING; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES MELLITUS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; GLUCOSE TOLERANCE; HEALTH EDUCATION; HEALTH PROGRAM; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LABORATORY TEST; LUNG DISEASE; MEDICAL CARE; MEDICAL RESEARCH; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NON PROFIT ORGANIZATION; NUTRITIONAL SUPPORT; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT CARE; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SELF CARE; SELF MONITORING; STOMACH PARESIS; TRANSPLANTATION; TREATMENT PLANNING;

CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE;

EID: 78651369030     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1768     Document Type: Review

References (72)

1. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631
2. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28:2141-2144 (Pubitemid 41242458)
3. Miller RJ, Tildesley HD, Wilcox PG, Zhang H, Kreisman SH. Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study. Can Respir J 2008;15:291-294
4. Sims EJ, Green MW, Mehta A. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 2005;28:1581-1587 (Pubitemid 40923068)
5. American Diabetes Association. Clinical Practice Recommendations-2010. Diabetes Care 2010;33(Suppl. 1):S1-S100
6. Sawaya GF, Guirguis-Blake J, LeFevre M, Harris R, Petitti D. Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med 2007 2007;147:871-875
7. Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J Pediatr 2008;152:540-545
8. Cawood TJ, McKenna MJ, Gallagher CG, Smith D, Chung WY, Gibney J, O'Shea D. Cystic fibrosis related diabetes in adults. Irish Med J 2006;99:83-86
9. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988;112:373-377 (Pubitemid 18079818)
10. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B, Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosis-related diabetes mellitus is tightly liked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-350
11. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005;146:681-687 (Pubitemid 40616255)
12. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162:891-895
13. Peraldo M, Fasulo A, Chiappini E, Milio C, Marianelli L. Evaluation of glucose tolerance and insulin secretion in cystic fibrosis patients. Horm Res 1998;49:65-71 (Pubitemid 28039394)
14. Rosenecker J, Höfler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, Posselt HG, Bargon J, von der Hardt H. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001;6:345-350
15. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfält R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002;33:483-491 (Pubitemid 34547870)
16. White H, Pollard K, Etherington C, Clifton I, Morton AM, Owen D, Conway SP, Peckham DG. Nutritional decline in cystic fibrosis-related diabetes: the effect of intensive nutritional intervention. J Cyst Fibros 2009;8:179-185
17. Tofé S, Moreno JC, Máiz L, Alonso M, Escobar H, Barrio R. Insulin secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005;152:241-247 (Pubitemid 40309571)
18. Hunkert F, Lietz T, Stach B, Kiess W. Potential impact of HbA1c determination on clinical decision making in patients with cystic fibrosis-related diabetes (Letter). Diabetes Care 1999;22:1008-1010 (Pubitemid 29241067)
19. Franzese D, Valerio G, Buono P, Spagnuolo MI, Sepe A, Mozzillo E, De Simone I, Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J Pediatr Endocrinol Metab 2008;21:109-116 (Pubitemid 351454563)
20. Elder DA, Wooldridge JL, Dolan LM, D'Alessio DA. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007;151:653-658 (Pubitemid 350116132)
21. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003;142:128-132 (Pubitemid 36232900)
22. Holl RW, Buck C, Babka C, Wolff A, Thon A. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. Diabetes Care 2000;23:126 (Pubitemid 30022909)
23. Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab 2008;34:568-573
24. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: a five year prospective study. BMJ 1995;311:655-659
25. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis-related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999;54:40-43 (Pubitemid 29103750)
26. International Organization for Standardization. Requirements for in vitro blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/TC 212/WG 3. Draft International Standard ISO/DIS 15197; Geneva, ISO, 2001
27. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007;30:1056-1061 (Pubitemid 46684624)
28. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H, Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy trial. Diabetes Care 2009;32:1783-1788
29. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001;90:860-867 (Pubitemid 32762829)
30. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatrica 1994;83:849-853 (Pubitemid 24281615)
31. Goss CH, Rubenfeld GD, Otto K, Aitken ML. The effect of pregnancy on survival in women with cystic fibrosis. Chest 2003;124:1460-1468 (Pubitemid 37290058)
32. Hardin DS, Rice J, Cohen RC, Ellis KJ, Nick JA. The metabolic effects of pregnancy in cystic fibrosis. Obstet Gynecol 2005;106:367-375 (Pubitemid 41023277)
33. McMullen AH, Pasta DJ, Frederick PD, Konstan MW, Morgan WJ, Schechter MS, Wagener JS. Impact of pregnancy on women with cystic fibrosis. Chest 2006;129:706-711
34. Bradbury RA, Shirkhedkar D, Glanveill AR, Campbell LV. Prior diabetes mellitus is associated with increased morbidity in cystic fibrosis patients undergoing bilateral lung transplantation: an "orphan" area? A retrospective case-control study. Intern Med J 2009;39:384-388
35. Hadjiliadis D, Madill J, Chaparro C, Tsang A, Waddell TK, Singer LG, Hutcheon MA, Keshavjee S, Elizabeth Tullis D. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clin Transplant 2005;19:773-778 (Pubitemid 41748731)
36. Mekeel KL, Langham MR Jr, Gonzalez-Perralta R, Reed A, Hemming AW. Combined en bloc liver pancreas transplantation for children with CF. Liver Transpl 2007;13:406-409 (Pubitemid 46444470)
37. Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet 1992;339:1583-1587
38. Mueller-Brandes C, Holl RW, Nastoll M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 2005;25:715-717 (Pubitemid 40528767)
39. Sosenko JM, Palmer MP, Rafkin-Mervis L, Krishcher JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS; Diabetes Prevention Trial-Type 1 Study Group. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009;32:1603-1607
40. Ode KL, Frohnert B, Laguna T, Phillips J, Holmes B, Regelmann W, Thomas W, Moran AM. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes. 25 February 2010 [Epub ahead of print]
41. Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER. Cystic fibrosis-related diabetes: thepresenceof microvascular diabetes complications. Diabetes Care 2006;29:2660-2663 (Pubitemid 44912195)
42. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiøtz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994;83:72-77 (Pubitemid 24072085)
43. Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998;92:871-872 (Pubitemid 28360617)
44. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell PW, Chesrown SE, Duchow C, Fink RJ, Fitz Simmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Tullis DE, Zipf WB. Diagnosis, screening, and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999;45:61-73 (Pubitemid 29356125)
45. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002 (Pubitemid 351656454)
46. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-1348
47. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, Messina MF, Crisafulli G, Wasniewska M, Valenzise M, Cucinotta D. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003;149:53-59 (Pubitemid 36874204)
48. Collins S, Reynolds F. How do adults with cystic fibrosis cope following a diagnosis of diabetes? J Adv Nurs 2008;64:478-487
49. Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P, Raia V. One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatric Diabetes 2009;10:162-167
50. Hardin DS, Rice J, Rice M, Rosenblatt R. Use of the insulin pump to treat cystic fibrosis-related diabetes. J Cyst Fibros 2009;8:174-178
51. Mohan K, Israel KL, Miller H, Grainger R, Ledson MJ, Walshaw MJ. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration 2008;76:181-186
52. Rafii M, Chapman K, Stewart C, Kelly E, Hanna A, Wilson DC, Tullis E, Pencharz PB. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 2005;81:421-426 (Pubitemid 43073344)
53. Hayes DR, Sheehan JP, Ulchaker MM, Rebar JM. Mangement dilemmas in the individual with cystic fibrosis and diabetes. J Am Diet Assoc 1994;94:78-80 (Pubitemid 24042189)
54. Franzese A, Spagnuolo MI, Sepe A, Valerio G, Mozzillo E, Raia V. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes? Diabetes Care 2005;28:2333
55. Grover P, Thomas W, Moran A. Glargine versus NPH insulin in cystic fibrosis related diabetes. J Cyst Fibros 2008;7:134-136 (Pubitemid 351372762)
56. Onady GM, Langdon LJ. Insulin versus oral agents in the management of cystic fibrosis related diabetes: a case based study. BMC Endocr Disord 2006;6:4
57. Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001;24:1706-1710 (Pubitemid 33716470)
58. Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid in continuous glucose monitoring in cystic fibrosis (Letter). Diabetes Care 2003;26:1940-1941 (Pubitemid 36929150)
59. Moreau F, Weiller MA, Rosner V, Weiss L, Hasselmann M, Pinget M, Kessler R, Kessler L. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm Metab Res 2008;40:502-506
60. Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005;147:396-398 (Pubitemid 41345774)
61. Mansour KM. Investigation of screening methods for impaired glucose control in children with cystic fibrosis. TSMJ 2000;1:7-11
62. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-259
63. Brunzell C, Schwarzenberg SJ. CFRD and abnormal glucose tolerance: overview and medical nutrition therapy. Diabetes Spectr 2002;15:124-127
64. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H, Clinical Practice Guidelines on Growth and Nutrition Subcommittee, Ad Hoc Working Group, for the Clinical Practice Guidelines on Growth and Nutrition Subcommittee. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systemic review. J Am Diet Assoc 2008;108:832-839 (Pubitemid 351602057)
65. Flume PA, Robinson KA, O'Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, Marshall BC, Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54:522-537
66. Swartz LM, Laffel LM. A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema. Pediatr Diabetes 2008;9:426-430
67. Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Daccò V, Bertoli S, Crosignani A, Colombo C. Spontaneous hypoglycemia in patients with cystic fibrosis. Eur J Endocrinol 2007;156:369-376 (Pubitemid 46554505)
68. Tierney S, Webb K, Jones A, Dodd M, McKenna D, Rowe R, Whitehouse J, Deaton C. Living with cystic fibrosis-related diabetes or type 1 diabetes mellitus: a comparative study exploring health-related quality of life and patients' reported experiences of hypoglycaemia. Chronic Illn 2008;4:278-288
69. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991;118:715-723
70. van den Berg JM, Morton AM, Kok SW, Pijl H, Conway SP, Heijerman HG. Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 2008;7:515-519
71. Dykewicz MS. Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol 2004;4:267-270 (Pubitemid 39006840)
72. Sullivan MM, Denning CR. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 1989;84:642-646